Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - CHANGE IN WORKING CAPITAL
Change in Working Capital URGN - UroGen Pharma Ltd.
4.93 M
LAST VALUE
66.80%
2 YEAR CAGR
2.69%
5 YEAR CAGR
41.62%
10 YEAR CAGR